Molecular Imaging 2017

Response Assessment: MRI

Restaging:  Presence/absence of tumour

 Presence/absence of suspicious mesorectal lymph nodes  Presence/absence of suspicious extra- mesorectal lymph nodes  yTNM staging

 Distance from anal verge  Tumour length  Location  Extramural extension

(mm), location & distance to CRM  Presence/absence of fibrosis

ESGAR Consensus. Beets-Tan et al. Eur Radiol. 2013; 23: 2522-31